Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Non-cash Items: 2018-2024

Historic Non-cash Items for OptimizeRx (OPRX) over the last 7 years, with Q4 2024 value amounting to $813397.0.

  • OptimizeRx's Non-cash Items fell 2223.74% to $813397.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $813397.0, marking a year-over-year decrease of 2223.74%. This contributed to the annual value of $813397.0 for FY2024, which is 2223.74% down from last year.
  • OptimizeRx's Non-cash Items amounted to $813397.0 in Q4 2024, which was down 2223.74% from $4.1 million recorded in Q3 2024.
  • In the past 5 years, OptimizeRx's Non-cash Items ranged from a high of $4.1 million in Q3 2024 and a low of $26410.0 during Q1 2021
  • Its 5-year average for Non-cash Items is $1.0 million, with a median of $652698.5 in 2024.
  • In the last 5 years, OptimizeRx's Non-cash Items crashed by 9580.74% in 2020 and then soared by 56662.42% in 2023.
  • Over the past 5 years, OptimizeRx's Non-cash Items (Quarter) stood at $1.5 million in 2020, then plummeted by 94.93% to $78334.0 in 2021, then soared by 100.31% to $156910.0 in 2022, then skyrocketed by 566.62% to $1.0 million in 2023, then dropped by 22.24% to $813397.0 in 2024.
  • Its Non-cash Items stands at $813397.0 for Q4 2024, versus $4.1 million for Q3 2024 and $492000.0 for Q1 2024.